AUCTORES
Globalize your Research
Chat with us
Research Article | DOI: https://doi.org/10.31579/2690-1919/124
Associate Professor, Medicine, Ad-din Women’s Medical College Hospital, Dhaka, Bangladesh.
*Corresponding Author: Richmond Ronald Gomes, Associate Professor, Medicine, Ad-din Women’s Medical College Hospital, Dhaka, Bangladesh.
Citation: Richmond RG. Lupus Nephritis: Role of Serum Complement Levels as Prognostic Marker. J Clinical Research and Reports, 6(1); DOI:10.31579/2690-1919/124
Copyright: © 2020 Richmond RG. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 26 August 2020 | Accepted: 21 September 2020 | Published: 21 November 2020
Keywords: lupus nephritis (LN); serum complements; systemic lupus erythematosus (SLE)
Background: Lupus Nephritis (LN) is one of the most common and serious manifestations in Systemic Lupus Erythematosus (SLE) patients that causes significant morbidity and mortality. Certain biomarkers for LN are sometimes able to assess treatment response of lupus nephritis.
Objective: To compare serum complement levels (C3 & C4) as markers of treatment response of LN and their relation to the LN class in renal biopsy.
Methods: This prospective observational study was conducted in the Department of Nephrology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh from July 2018 to August 2019. Twenty seven patients who were diagnosed with lupus nephritis after kidney biopsy were included in this study. Serum complement levels (C3 & C4), 24 hours urinary total protein (24-hr UTP) and anti-double-stranded DNA (anti-ds DNA) were measured in all patients at baseline, 3 months and 6 months after treatment. These biomarker values before and after treatment were compared between the treatment response and non response groups.
Results: Serum C3 levels were significantly different in patients of proliferative lupus nephritis (Class III & Class IV) than non proliferative lupus nephritis (Class V) at baseline (0.47 ± 0.32 vs0.89 ± 0.43g/l, p = 0.009) and levels changed significantly 6 months after treatment (p <0.001) and likewise for Serum C4 levels (0.10 ± 0.06 vs0.24 ± 0.26g/l, p = 0.040). Serum C3 levels were also found to correlate significantly with SLEDAI and renal SLEDAI. No significant difference was observed for 24-hr UTP levels at baseline between remission and non-remission groups.
Conclusion: Serum C3 & C4 levels may be utilized as serological biomarkers to predict and monitor the treatment response of lupus nephritis.
Systemic Lupus Erythematosus (SLE) is an autoimmune disease which affects almost every system in the body with different degrees of severity [1]. The clinical features of this chronic disease may vary from person to person; ranging from mild joint pain and skin involvement to severe, life-threatening internal organ damage [2] [3]. Renal involvement in SLE termed as lupus nephritis (LN) is one of the most common manifestations of SLE and continues to be a major contributor to morbidity and mortality [4]. The pathogenesis of lupus nephritis (LN) is a complicated process; including glomerular deposition of autoantibodies, complement activation, cellular proliferation, release of chemokines and proinflammatory cytokines leading to inflammation and fibrosis and it is a serious complication in SLE since it is the major forecaster of poor prognosis [5, 6, 7].
Up to 50% of SLE patients will have clinically evident kidney disease at presentation; during follow-up, renal involvement will occur in 60% of patients [8]. Clinical course ranges from asymptomatic urinary occult blood to nephrotic syndrome or acute kidney injury since kidney injuries in LN are so variable [9].
All four renal compartments glomeruli, tubules, interstitium, and blood vessels may be affected in LN [10]. In addition; if LN develops early in the course of SLE, it becomes a major predictor of poor prognosis [11]. It has been reported that; in spite of remarkable progression in treatment, up to 25% of SLE patients progress to end-stage renal failure 10 years after the onset of renal damage and the 5-year survival of nephritis patients is stalled at 82%, whereas 5-year survival for those without nephritis is 92% [10, 12, and 13].
Despite the fact that several efficacious therapies have been used to treat lupus nephritis, the incidence of end-stage renal disease (ESRD) from lupus nephritis increased day by day. This may reflect the limitations of our current treatment options, poor access to health care, late diagnosis, delay in treatment and lack of follow-up the response of treatment [14]. Earlier treatment has a beneficial effect on the prognosis of lupus nephritis; and it has been shown that late diagnosis of lupus nephritis is correlated with a higher frequency of renal insufficiency [14, 15]. Moreover, delayed diagnosis is associated with an increased incidence of ESRD [15].
Certain laboratory markers which may be used for assessment of lupus nephritis are proteinuria, urine protein creatinine ratio, creatinine clearance, anti-double-stranded DNA (anti-dsDNA) antibodies, and complement levels [16]. It was observed, however, that these parameters, namely anti-dsDNA antibodies, complement levels, proteinuria, creatinine clearance and urinary sediment are not specific enough to detect disease activity in renal involvement and nephritis relapse [17]. Anti-dsDNA antibodies are necessary but not sufficient for the development of lupus nephritis exacerbations [18].
Anti-dsDNA antibody assays can be negative early in disease, after treatment, or when the patient is in clinical remission; therefore, not all patients with SLE are seropositive at any one time [19]. However, these traditional markers are often not as specific as desired in situations of diagnostic dilemma [16]. Repeat kidney biopsy, though useful, is an invasive procedure with its own complications [5]. Previous reports have demonstrated that focal, diffuse proliferative and membranous nephritides (World Health Organization LN classes III, IV, V) have poor prognosis, especially class IV LN and they usually require active interventions to inhibit their progression to renal failure [20].
To date, studies have produced conflicting reports regarding correlation of serum C3 and C4 levels in such patients with renal disease activity and prognosis [20]. Assessment of response to treatment using proteinuria as the sole biomarker have also not correlated well with renal functional recovery. This study aims to evaluate such biomarkers with renal SLEDAI scores [21] to see whether any biomarker can be used satisfactorily to indicate severity and prognosis of lupus nephritis.
This prospective observational study was conducted in the Department of Nephrology and Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh from July 2018 to August 2019 among twenty seven patients (27) who were diagnosed with lupus nephritis after kidney biopsy. The study was approved by the Ethical Review Committee, BSMMU, and Dhaka, Bangladesh.
Adult SLE patients, diagnosed as LN admitted in the Nephrology department with urinary total protein > 0.5 gm were included in this study. Pregnant women and lactating mothers, patients with malignancy, patients with active infection, patients with autoimmune disease other than SLE and end stage renal disease (ESRD) or dialysis dependent CKD patients were excluded from the study.
Informed written consents to participate in this study and undergo renal biopsy were recorded before undertaking the procedure. The renal histology was classified according to the International Society of Nephrology/Renal Pathology Society [22]. According to the abbreviated version of the classification, combined classes III/V or IV/V were considered as class III or IV, respectively. Out of those patients who were class III, IV and V LN diagnosed histologically without any features of exclusion criteria and willing to participate in this study were finally enrolled for this study. Renal SLEDAI (rSLEDAI) [21] was used to assess kidney disease activity.
Before starting the treatment base line levels of Complete blood count (CBC), Erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), Urine- routine microscopic examination (Urine- R/M/E), Urinary total protein (UTP), Serum Creatinine, Serum Electrolytes, Serum alanine aminotransferase (ALT), Antinuclear antibody (ANA), Anti-double-stranded DNA (Anti-dsDNA) antibody and Serum levels of complement components 3 and 4 (C3 & C4) were measured in study patients. After initiation of treatment, CBC, ESR, Urine R/M/E, UTP, Serum Creatinine, Anti-dsDNA and serum levels of C3 & C4 were again measured at 3rd and 6th months. Each study patients received either intravenous Cyclophosphamide (NIH protocol) [23] or Mycophenolate mofitel (MMF -2 gm/day) [24] as induction therapy for 6 months.
2.1. Statistical analysis:
Statistical analyses were performed by using windows based computer software with Statistical Packages for Social Sciences (SPSS-23) (Armonk, NY: IBM Corp). Level of significance was examined by paired‘t’-test, unpaired‘t’-test and Chi-square test. For all statistical tests, we considered p value <0.05 as statistically significant.
A total number of 27 patients were evaluated over the study period. Table I shows maximum patients (44.4%) were in the age group of 21 – 30 years. Females were predominant to males (24 versus 3) and most patients were in class IV group [13 (48.1%)].
Table 2 shows urine Routine microscopic examination (RME) findings of 27 lupus nephritis patients at baseline, after 3 months and after 6 months.
Table 3 shows Urine abnormalities at baseline according to different classes of lupus nephritis.
Table-4 shows laboratory parameters of the study subjects at baseline. At baseline Serum C3 and C4 levels are significantly lower and UTP is significantly higher (p=<0.001) in membranous/non-proliferative lupus nephritis (class V) then proliferative lupus nephritis (class III+IV).
Table-5 show pre-treatment (at baseline) and post treatment (after 6 month) value of different parameters in proliferative (Class III & Class IV) and non-proliferative/membranous (Class V) lupus nephritis. The values of 24-hr UTP and Anti ds DNA were significantly different before and after treatment with p value <0.05 in both groups but C3 and rSLEDAI were only significant in the proliferative group. C4 was not significant in both groups.
Lupus nephritis (LN) is an immune-mediated glomerulonephritis that is a common consequence in patients with SLE. In this prospective observational study, a total of 27 patients with lupus nephritis were recruited. Most of the study subjects were females 24 (88.9%). Maximum were in the age group of 21 – 30 (44.4%) years. This finding was consistent with previous studies [24] [25] [26]. This can be explained by the fact that lupus nephritis is more common in females.
Renal biopsy was done in all patients. Among 27 lupus nephritis patients, the most common histopathological type was class IV (48.1%) followed by class V (33.3%) and class III (18.5%). Near similar findings were observed in a study done by Sharma et al., (2019) [27] where the most common histopathological type was class IV (50%), followed by class III (17.6%) and class V (9%) and in another study by Gupta et al., (2015) [5] where Proliferative glomerulonephritis (class III and IV) was detected in 31 (68.8%) patients and class II and class V LN was detected in seven (15.5%) patients each. In both study number of class V lupus nephritis patient is less than class III probably due to two factors. Firstly, in both study all class of LN patients were included and secondly, combined class (III + V) and class (IV + V) lupus nephritis patient was more in both groups.
In our study serum complement components (C3 and C4) levels were found to have improved (become higher) in both proliferative and non-proliferative lupus nephritis groups from baseline to 6 months post treatment initiation, although not significantly always. Similar findings were observed in a study done by Davas et al., (1999) [28] where 19 patients from lupus nephritis group were assessed at presentation and 6 months after treatment. Another study done by Gupta et al., (2015) [5], they recruited 45 patients who all had renal biopsy and similar results were observed. The same results were found for 24 hrs UTP, anti-dsDNA in both group but C3 and rSLEDAI decreased significantly in only proliferative group. No difference was found for C4 levels in both groups. Similar findings were observed in a study done by Davas et al., (1999) [28].
Several published studies have evaluated several serologic markers for lupus nephritis. Decreased levels of C3 and C4, elevated anti-ds DNA and increased proteinuria have been found to correlate with worsening disease activity. Our study produced similar findings in concert with these previous studies [24-28]. From the above results it seems clear that C3 and C4 are reliable markers of disease activity in patients with lupus nephritis.
This study permits to conclude that serum complement levels in patients with lupus nephritis correlate with disease activity. After 6 months of treatment serum complement levels increased towards normal in both proliferative and non-proliferative lupus nephritis groups. Hence, serum C3 and C4 may be used as tools to detect disease severity and to monitor treatment response in lupus nephritis.
It was a single centre study with a relatively small sample size.
A multi-center prospective study with large sample size should be done to compare other biomarkers as a marker of treatment response of lupus nephritis (LN) and their relation to the LN classes.
The authors declare no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
